Skip to content
Guavy Logo GUAVY
Sign up
Back to Guavy Wire
Stocks

GuruFocus: JNJ Overvalued by Nearly 110% According to DCF Analysis

Guavy AI Editorial Team
Instruments
JNJ
Share

Johnson & Johnson (JNJ) is significantly overvalued at its current price of $260.35, according to GuruFocus' Discounted Cash Flow (DCF) analysis.

The DCF earnings-based model calculates the intrinsic value of JNJ at $123.97, indicating a margin of safety of -110.0%.

Additionally, the free cash flow (FCF)-based intrinsic value for JNJ is calculated at $105.26, also suggesting that the stock is overvalued with a margin of safety of -147.3%.

The consensus from both DCF models and the GF Value model indicates that Johnson & Johnson is significantly overvalued.

More on Stocks

Stocks 2m ago

Tech Data Expands IBM Distribution Across Asia Pacific

Stocks 3m ago

Singapore Set for Quantum-Safe Cybersecurity Hub with SIT, IBM Partnership

Stocks 3m ago

Singapore Institutes Quantum Security Hub with Help from IBM

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Guavy Logo GUAVY

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

Navigate

Markets

Resources

© 2026 Guavy Inc

Terms Privacy Policy